Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

By D. Lloyd‐Jones, Thomas J. Wang, E. Leip, Martin G. Larson, Daniel Levy, Ramachandran S. Vasan, Ralph B. D’Agostino, J. Massaro, A. Beiser, P. Wolf and 1 more. Circulation, 2004

2,126 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “The lifetime risk of developing AF is "25% in those who have reached the age of 40.(8) The prevalence and incidence of AF in non-Caucasian populations is less well studied.”
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006, positive): “The age-adjusted incidence increased over a 30-y period in the Framingham Study (32), and this may have implications for the future impact of AF (34).”
The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and Costs (2009, background): “Incidence The lifetime risk for AF in persons without HF or MI is approximately 15% at 40 years of age and also at 80 years of age.(31) Overall incidence rates of AF in the CHS men and women were 26.”
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2013, neutral): “Saudi Med J 2007 September;28(9):1457-9.”